MYCN and retinoblastoma: DNA methylation and gene expression profiling in further RB1-proficient MYCN-amplified retinoblastomas will help to better characterize differences in molecular circuitry in RB1−/− and RB1-proficient MYCN-amplified retinoblastoma.